<DOC>
	<DOCNO>NCT01608542</DOCNO>
	<brief_summary>This single multiple dose study healthy male female ( non-child bearing potential ) Japanese volunteer , assess blood urine drug level Fostamatinib . Fostamatinib develop treatment rheumatoid arthritis .</brief_summary>
	<brief_title>A Single Multiple Dose Study Assess Blood Urine Drug Levels Fostamatinib Healthy Japanese Subjects</brief_title>
	<detailed_description>A Phase I , Open-label Study Assess Pharmacokinetics Oral Fostamatinib Healthy Japanese Subjects After Single Multiple Doses</detailed_description>
	<criteria>Healthy male female ( nonchildbearing potential ) Japanese subject 20 45 year age Body mass index ( BMI ) 17 27 kg/m2 weigh least 45 kg 100 kg History presence respiratory , GI , renal , hepatic , hematological , lymphatic , neurological , cardiovascular , psychiatric , musculoskeletal , genitourinary , immunological , dermatological , connective tissue diseases disorder Any clinically significant illness , acute infection , know inflammatory process , medical/surgical procedure trauma within 4 week first administration investigational product Smoking excess 5 cigarette per day equivalent within 30 day Day 1 Use prescription overthecounter drug within 2 week first administration investigational product Previous participation fostamatinib study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>fostamatinib</keyword>
	<keyword>FosD</keyword>
	<keyword>Japanese Healthy volunteer</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Single Multiple Dose Study</keyword>
</DOC>